Publications by authors named "Santiago Alfonso Zamora"
Introduction: Psoriasis is a chronic disease involving the skin, which significantly impacts the quality of life. Disease severity and treatment efficacy (i.e.
View Article and Find Full Text PDFAssessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis.
Néboa Zozaya Fernando Abdalla Santiago Alfonso Zamora Jesús Balea Filgueiras José Manuel Carrascosa Carrillo
Expert Rev Pharmacoecon Outcomes Res
September 2022
Article Synopsis
- - Multi-criteria decision analysis (MCDA) was used to improve clinical decisions for biological therapies in psoriasis, highlighting bimekizumab's effectiveness over various treatment options.
- - The EVIDEM framework helped assess the therapies, with expert opinions translating into a model that evaluated the drug's benefits and consistency in scoring.
- - Bimekizumab demonstrated significant therapeutic advantages, offering better patient outcomes while maintaining safety, making it a strong choice for moderate-to-severe psoriasis compared to other treatments.
Psoriasis is a chronic, systemic inflammatory disease that affects the skin, with a high impact on patients' quality of life. The aim of this study was to identify and determine the relative importance of unmet needs in the management of moderate-to-severe psoriasis in Spain, from a multi-stakeholder perspective. A mixed method-approach was used to collect information, design a questionnaire and a discrete-choice exercise, and elicit the unmet needs through a multidisciplinary committee composed of 12 experts.
View Article and Find Full Text PDF